100Xfounder
Get Featured

Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

About Karius

The Problem Karius addresses a core biotech pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.

The Solution Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare In practice, Karius centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.

Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Karius is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Culture The team operates in a fast-paced environment focused on biotech innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.

Why it Matters

Karius matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Karius is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Funding Snapshot

Total Funding: $165.00MLast Round: Series B Khosla Ventures, $165M Series B in 2020All Rounds: 1
  • Series BKhosla Ventures, $165M Series B in 2020

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: February 23, 2026

Karius intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Biotech with comparable market signals.

Discover Now

Newsroom and topic pages connected to Karius.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Karius

Common questions people ask about this profile.

What is Karius?

Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

Who founded Karius?

Karius is associated with Karius Team on 100Xfounder.

Where is Karius located?

Karius is listed in San Francisco Bay Area, California, USA.

What stage is Karius in?

Karius is currently mapped to Series B. Funding context: Khosla Ventures, $165M Series B in 2020

What is the latest funding round of Karius?

Karius's latest tracked round is Series B Khosla Ventures, $165M Series B in 2020. Total tracked rounds: 1.

Is Karius hiring now?

Karius hiring status: Open Roles.

What technologies does Karius use?

Karius is associated with AWS, React, Python, and PostgreSQL.

Is Karius verified on 100Xfounder?

Yes. Karius is currently marked verified on 100Xfounder as of March 3, 2026.

How can users connect with Karius founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.